Hot Trucking Stocks To Buy For 2014

The exportation of liquefied natural gas, or LNG, has been a hotly debated topic in the United States recently. Companies from all types of backgrounds have been staking their claims on either side of the argument. One thing is for certain, and that is that in 2015 Cheniere Energy (NYSEMKT: LNG  ) will begin exporting liquefied natural gas from its Department of Energy-approved Sabine Pass facility.��

Aside from the potential growth in exports from North America, Australia looks to be the largest contributor to the growth of natural gas finding its way into the international trade market. Transportation of natural gas chilled to temperatures as low as -260 degrees Fahrenheit certainly requires a high degree of skilled execution. That's where Teekay LNG Partners (NYSE: TGP  ) enters the picture. With a fleet much younger than the industry average and a distribution over 6%, it could be a great second-degree play on the coming trend.

If exports are allowed unchecked, will nat-gas prices negatively affect CLNE?
The movement toward alternative energy is gaining momentum. One potential opportunity in this field is Clean Energy Fuels, which focuses its natural gas efforts primarily on trucking and fleets. It's poised to make a big impact on an essential industry. Learn everything you need to know about Clean Energy Fuels in The Motley Fool's premium research report on the company. Just click here now to claim your copy today.

5 Best Shipping Stocks To Watch Right Now: ImmunoGen Inc.(IMGN)

ImmunoGen, Inc. engages in the research and development of targeted therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies, and highly potent cell-killing agents. The company develops its products using its Targeted Antibody Payload (TAP) technology. Its product candidates include Trastuzumab emtansine (T-DM1), a Phase III clinical trial product for HER2+ breast cancer; lorvotuzumab mertansine (IMGN901), a Phase I clinical trial product, which targets CD56 found on small-cell lung cancer, Merkel cell carcinoma, multiple myeloma, ovarian cancers, carcinoid tumors, and other cancers of neuroendocrine origin; IMGN529, a pre-investigational new drug stage drug for CD37+ B-cell malignancies, such as non-Hodgkin's lymphoma; and IMGN853, a preclinical stage product for cancers that overexpress folate receptor 1, including ovarian cancer. The company?s earlier-stage compounds in development stage comprise SAR3419, a Phase I clinical trial product for CD19+ B-cell malignancies, including non-Hodgkin's lymphoma; SAR650984, a Phase I clinical trial product for CD38+ hematological malignancies; SAR566658, a phase one clinical trial product for DS6+ solid tumors; and BT-062, a Phase I product for multiple myeloma. It has collaboration agreements with Amgen, Inc.; Bayer Schering Pharma AG; Biogen Idec MA Inc.; Biotest AG; Genentech, Inc.; Novartis Institutes for BioMedical Research, Inc.; and sanofi-aventis U.S. LLC. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.

Advisors' Opinion:

• [By RichardCox]

  While it is important to seek out well-established companies with a proven product line, it should be remembered that it is still possible to find long-term opportunities in companies that are still in the clinical stage. In these cases, risk can be reduced by identifying those companies with a diversified set of drug innovations. So, when smaller companies are limited in the types of diseases and treatments, there is generally less protection from investment risk. One example of a smaller company with strong product positioning is ImmunoGen (IMGN).

• [By Sean Williams]

  A moat of competition, but plenty of upside
  However, investors would probably be wise not to get too carried away with yesterday's news given that another therapy -- which I would certainly call revolutionary�-- known as Kadcyla for HER2-positive breast cancer was just approved in February. Kadcyla, developed by Roche�and ImmunoGen (NASDAQ: IMGN  ) piggybacks a toxin on an antibody and, using ImmunoGen's proprietary targeted antibody payload technology, delivers a higher dose of toxin directly to the targeted cancer, which has a signature protein that causes the release of the toxin from the antibody. In late-stage trials, Kadcyla improved PFS by 50% over the placebo to 9.6 months.

Hot Trucking Stocks To Buy For 2014: Inchcape PLC (INCH)

Inchcape plc is a global premium automotive distributor and retailer. The Company provides a professional and financed route to market for automotive manufacturers across five continents. Inchcape acts as a vehicle and parts distributor in 22 of its 26 markets. In these markets, the Company has responsibility for managing the value chain on behalf of a focused portfolio of premium and luxury brand partners. The Company�� responsibilities as a distributor include specifying vehicles to meet local market requirements, organizing logistics from the factory gate through to the retail center, appointing and performance managing the retail network and acting as the national marketer of the brand. The Company derives over two third of its profit from Asia Pacific and emerging markets. Its markets include Hong Kong, Singapore, Russia, Chile, Ethiopia, Australia and the United Kingdom. Advisors' Opinion:

• [By Inyoung Hwang]

  Inchcape Plc (INCH) surged 9.9 percent to 645 pence, the highest level since June 2008. The largest publicly traded U.K. car retailer and wholesaler reported first-half adjusted pretax earnings increased 11 percent. The company also announced share buybacks of 100 million pounds in the next year.

Hot Trucking Stocks To Buy For 2014: Qihoo 360 Technology Co. Ltd.(QIHU)

Qihoo 360 Technology Co. Ltd. provides Internet and mobile security products in the People's Republic of China. Its principal products include 360 Safe Guard, an Internet security product for Internet security and system optimization; 360 Anti-Virus, an anti-virus application to protect users? computers against trojan horses, viruses, worms, adware, and other forms of malware; and 360 Mobile Safe, a security program for the Google Android, Apple iOS, and Nokia Symbian smartphone operating systems. The company?s platform products comprise 360 Safe Browser, a Web browser; 360 Personal Start-up Page, a default homepage of 360 Safe Browser and a key access point to popular and preferred information and applications; 360 Application Store, a key access point to securely obtain and manage software and applications; and 360 Safebox, a solution that protects users against thefts of personal account information. It also provides online advertising services, including online marketi ng services and search referral services; and Internet value-added services comprising the operation of Web games developed by third-parties, remote technical support, and cloud-based services. The company was formerly known as Qihoo Technology Company Limited and changed its name to Qihoo 360 Technology Co. Ltd. in December 2010. Qihoo 360 Technology Co. was founded in 2005 and is based in Beijing, the People?s Republic of China.

Advisors' Opinion:

• [By Rick Munarriz]

  Qihoo 360 (NYSE: QIHU  ) invaded Baidu's (NASDAQ: BIDU  ) home turf of Chinese search, and now Baidu is relishing the chance to be the away team.

• [By Rick Munarriz]

  Is it a coincidence that Qihoo 360 (NYSE: QIHU  ) rolled out a rival search engine last summer and that Baidu has come up short in each of its first two reporting periods where it had to compete with Qihoo 360 for the entirety of the quarter?

• [By Paul Ausick]

  Friday’s big loser shortly after the opening bell appears to be Qihoo 360 Technology Co. Ltd. (NYSE: QIHU), down about 6.4% to $87.30, in a 52-week range of $27.76 to $96.74. At least part of the drop is due to an announcement that Alibaba has denied rumors that it will be taking a stake in the company. Daily average share volume was about 2.9 million and nearly 600,000 shares traded in the first 20 minutes or so of the session.

• [By Kevin Chen]

  In the video below, Fool contributor Kevin Chen shows how Baidu won out against Google� (NASDAQ: GOOG  ) and Qihoo� (NYSE: QIHU  ) , how SINA topped Tencent, and how Sohu has kept down Yahoo!. To learn more about how close these tech giants are to the Chinese government, watch the video now.

Hot Trucking Stocks To Buy For 2014: Universal Display Corp (OLED)

Universal Display Corporation, incorporated on April, 24, 1985, is engaged in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in flat panel display, solid state lighting and other product applications. The Company�� primary business strategy is to develop and license its OLED technologies to product manufacturers for use in these applications. Its primary business is to develop and license its OLED technologies to manufacturers of products for display applications, such as cell phones, portable media devices, tablets, laptop computers and televisions, and specialty and general lighting products; and develop new OLED materials and sell the materials to those product manufacturers. The Company sells its OLED materials to customers for evaluation and use in commercial OLED products. As of December 31, 2012, the Company owns, exclusively license or have the sole right to sublicense more than 3,000 patents issued and pending worldwide. On July 23, 2012, the Company entered into a Patent Sale Agreement (the Agreement) with FUJIFILM. Under the Agreement, FUJIFILM sold more than 1,200 OLED related patents and patent applications.

Phosphorescent Organic Light Emitting Diode Technologies

Phosphorescent OLEDs utilize specialized materials and device structures that allow OLEDs to emit light through a process known as phosphorescence. Traditional fluorescent OLEDs emit light through an inherently less efficient process. Theory and experiment show that phosphorescent OLEDs exhibit device efficiencies up to four times higher than those exhibited by fluorescent OLEDs. Phosphorescence substantially reduces the power requirements of an OLED and is potentially useful in displays for hand-held devices, such as Smartphone��, where battery power is often a limiting factor. Phosphorescence is also important for area displays such as televisions, where higher device efficiency and lower heat generation may enable longer ! product lifetimes and increased energy efficiency.

Additional Proprietary Organic Light Emitting Diode Technologies

Additional OLED Technologies include FOLED Flexible OLEDs, Thin-Film Encapsulation, UniversalP2OLED Printable Phosphorescent OLEDs, OVJP Organic Vapor Jet Printing, OVPD Organic Vapor Phase Deposition and TOLED Transparent OLEDs. The Company is working on a number of technologies required for the fabrication of OLEDs on flexible substrates. As of December 31, 2012, it was conducting research and development on FOLED technologies internally, under several of its United States government programs and in connection with the government-sponsored Flexible Display Center at Arizona State University (ASU). The Company announced its, patented encapsulation technology for the packaging of flexible OLEDs and other thin-film devices, as well as for use as a barrier film for plastic substrates. Its approach for manufacturing a small molecule OLED, including a PHOLED, is based on a vacuum thermal evaporation (VTE) process.

The Company has partnered with Aixtron AG, which is a manufacturer of metal-organic chemical vapor deposition equipment, to develop and qualify equipment for the fabrication of OLED displays utilizing the OVPD process. It has developed a technology for the fabrication of OLEDs that have transparent cathodes. TOLEDs use a transparent cathode and either a transparent, reflective or opaque metal anode.

Organic Light Emitting Diode Materials Supply Business

The Company supplies its proprietary UniversalPHOLED materials to display manufacturers and others. The Company qualifies its materials in OLED devices before shipment in order to ensure that they meet required specifications. During 2012, the Company continued supplying its proprietary UniversalPHOLED materials to SDC for use in its commercial AMOLED display products and for its development efforts. During 2012, the Company also supplied its UniversalPHOLED materials to! LG Displ! ay for use in its commercial AMOLED display products, to Tohoku Pioneer for use in its commercial PMOLED display products, and Konica Minolta for its manufacture of commercial OLED lighting products. During 2012, the Company also supplied its proprietary OLED materials to these and various other product manufacturers for evaluation and for purposes of development, manufacturing qualification and product testing.

The Company competes with Eastman Kodak Company (Kodak), Cambridge Display Technology, Ltd. (CDT), Sumitomo Chemical Company (Sumitomo), Idemitsu Kosan Co., Ltd. (Idemitsu Kosan), Merck KGaA and BASF Corporation.

Advisors' Opinion:

• [By Dan Caplinger]

  The stock market fought its way back from early losses on Friday, with investors taking heart from positive economic data, even as they prepared for the beginning of a new earnings season in the next couple of weeks. At least for now, it appears that policy makers will do their utmost to prevent any huge disruption in the stock market, and that boded well for shareholders today. In particular, shares of Universal Display (NASDAQ: OLED  ) , Taseko Mines (NYSEMKT: TGB  ) , and Organovo Holdings (NYSEMKT: ONVO  ) were among the best performers of the day, with their excitement helping to carry the whole market higher.

• [By John Udovich]

  Small cap display stock SGOCO Group Ltd (NASDAQ: SGOC) just sank 27.89% after reporting earnings, meaning its worth taking a closer look at it along with some other innovative display stocks like�Corning Incorporated (NYSE: GLW) and Universal Display Corporation (NASDAQ: OLED). After all, just about every new consumer gadget along with cars and even appliances are incorporating display technology. I should also mention that we have had Corning Incorporated in our SmallCap Network Elite Opportunity (SCN EO) portfolio since early December (we are up around 29.20%) as we believe the company is in the sweet spot for next generation flexible screens and mobile wearables.

• [By Steve Symington]

  Hold on to your hats, Universal Display Corp. (NASDAQ: OLED  ) investors, because it's time to delve into what to expect from your favorite OLED technologist in 2014.

Hot Trucking Stocks To Buy For 2014: Prana Biotechnology Ltd (PRAN)

Prana Biotechnology Limited engages in the research and development of therapeutic drugs for the treatment of neurological disorders in Australia. The company primarily focuses on the Alzheimer�s, Parkinson�s, and Huntington�s diseases, as well as various cancer, age-related macular degeneration and cataract, Motor Neuron, and Creutzfeldt-Jakob diseases. Its development stage product line comprises PBT2, a Phase IIb clinical trial product for the treatment of Alzheimer�s disease; and PBT2, a Phase IIa clinical trial product for the treatment of Huntington�s disease. The company was formerly known as Prana Corporation Ltd. and changed its name to Prana Biotechnology Limited in January 2000. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.

Advisors' Opinion:

• [By Bryan Murphy]

  Considering Eli Lilly & Co. (NYSE:LLY) as well as a co-development project between Johnson & Johnson (NYSE:JNJ) and Pfizer Inc. (NYSE:PFE) both failed in semi-recent effort to develop a similar-functioning Alzheimer's drug, it would be easy to assume that particular route towards an Alzheimer's might be the wrong path to take. Sometimes though, a small tweak or a seemingly-minor nuance with the underlying problem can make all the difference. Enter Prana Biotechnology Limited (NASDAQ:PRAN). Though the company acknowledges its focal point on the development of an Alzheimer's therapy is the same broad premise that ultimately led LLY, PFE, and JNJ to failure, PRAN may have found the proverbial missing link.

• [By James Brumley]

  SGNT stock is also valued at a palatable trailing P/E of 19.8, and has logged six straight quarterly earnings beats, making it one of the best cheap stocks in the pharmaceutical industry.

  Prana Biotechnology (PRAN)

  It’s a slippery slope when you start placing bets based on a company with no marketable product, and a lead candidate that’s only in Phase 2 trials. But, Prana Biotechnology (PRAN) may be one of those cheap stocks within the drugmaking world that’s worth the risk.

Hot Trucking Stocks To Buy For 2014: Vringo Inc. (VRNG)

Vringo, Inc., together with its subsidiaries, engages in the innovation, development, and monetization of mobile technologies and intellectual property. Its intellectual property portfolio consists of approximately 500 patents and patent applications covering telecom infrastructure, Internet search, and mobile technologies. The company operates a platform for the distribution of mobile social applications and services, including Facetones and Video Ringtones that transform the basic act of making and receiving mobile phone calls into a visual, social experience. Its Video Ringtones platform allows users to create, download, and share mobile entertainment content in the form of video ringtones for mobile phones; and Facetones is a social ringtone platform that allows users to create social picture ringtone and ringback content in the form of animated slideshows sourced from friends� social networks. The company also provides Fan Loyalty platform that allows users to obtain video and video ringtones, view information on reality television series and stars, and vote for contestants; and Video ReMix platform, which allows users to download an application for iPhone, iPad, iPod, or Android phones, and create their own music video by tapping on various music beats and video files. Vringo, Inc. is headquartered in New York, New York.

Advisors' Opinion:

• [By Markman Advisors]

  Public companies leveraging their patent portfolios, (aka "patent plays"), are getting the market's attention. Companies such as Vringo (VRNG), ParkerVision (PRKR), MGT Capital (MGT), Worlds Inc. (WDDD.OB) and others have presented trading opportunities due to their volatility while retaining the chance for a big payoff to those investors who stay the course. Yet there exist viable patent plays that are still undiscovered. Some of these so called "plays," which are not getting enough attention, are actually real companies making and selling real products or services in contrast to pure patent monetization companies. Some known examples are Single Touch Interactive (SITO.OB) and Blue Calypso (BCYP.OB). This article is focused on another one of these patent plays, On Track Innovations Ltd. (OTIV).

• [By Bryan Murphy]

  I'll be honest... I would have thought by now that the Vringo, Inc. (NASDAQ:VRNG) saga - the patent lawsuit brought against Google (NASDAQ:GOOG) and some of its partners - would have fallen off the radar by now as the market lost interest. On the other hand, I also would have thought by now that the trial would have been completed in its entirety by now. We're close to an end (less the appeal, if Vringo decides it needs to go through with it, or if Google decides to make an appeal of its own); we learned in mid-August the court intends to accept responsive/rebuttal briefs through November 10th, and may after that schedule any evidentiary hearings. But, those hearings will only be held if needed. Soon after that, we'll hear what most have been waiting for nearly two years now ... the actual size of the check that Google will need to write to Vringo Inc.

• [By Susan Decker]

  Public-market investors have to be prepared for a bumpy ride. Spherix, with a market value of $23.6 million, has dropped 11 percent since the merger closed. Vringo Inc. (VRNG), a provider of software for mobile and video applications, has tumbled 19 percent since merging with intellectual property company Innovate/Protect Inc.

• [By Lauren Pollock]

  Vringo Inc.(VRNG) said a Germany court found that Chinese telecommunications firm ZTE Corp.(000063.SZ) infringed one of its European patents and is required to pay damages. Shares of the small mobile technology and intellectual-patent firm jumped 10% premarket to $3.40.